Treatment of cancer-related pain with transdermal buprenorphine: a report of three cases
- 9 October 2004
- journal article
- research article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 12 (12) , 882-884
- https://doi.org/10.1007/s00520-004-0695-1
Abstract
Three patients suffering from pain arising from renal and metastasing prostate and breast cancer were successfully treated with transdermal buprenorphine. The three cases demonstrate that transdermal buprenorphine is an easy-to-use and effective therapeutic option for the treatment of advanced cancer pain, that it can also be used in opioid rotation as an alternative after formerly applied steps II or III opioids have failed and that long-term treatment without dose escalation or compromise in tolerability is possible.Keywords
This publication has 10 references indexed in Scilit:
- Efficacy and tolerability of a new opioid analgesic formulation, buprenorphine transdermal therapeutic system (TDS), in the treatment of patients with chronic pain. A randomised, double-blind, placebo-controlled studyThe Pain Clinic, 2003
- III. Old dog'new (ma)trix † †Declaration of interest. Dr Collett was a member of the Transtec Advisory Board (two Meetings) organised by Napp Pharmaceuticals and has been in receipt of three travel grants from that company over the last 5 years. Dr Budd was a member of the Transtec Advisory Boards of Napp Pharmaceuticals and Grunenthal GmbH and has received lecture and travel expenses from both companies.British Journal of Anaesthesia, 2003
- Buprenorphine and the transdermal system: The ideal match in pain management2003
- Buprenorphine TDS: the clinical development rationale and results.2003
- Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: A multicenter, randomized, double-blind, placebo-controlled trialClinical Therapeutics, 2003
- Buprenorphine in a Transdermal Therapeutic System – A New OptionClinical Rheumatology, 2002
- Transdermal fentanyl for the management of cancer pain: a survey of 1005 patientsPalliative Medicine, 2001
- Treatment of cancer pain with transdermal fentanylThe Lancet Oncology, 2001
- Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective studyPain, 1995
- BuprenorphineDrugs, 1979